SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 1-A/A - Offering Statement [Regulation A]: [Amend]
SEC Accession No. 0001493152-22-012733
Filing Date
2022-05-10
Accepted
2022-05-10 17:29:11
Documents
9

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 1-A/A  
1 primary_doc.xml 1-A/A 11389
2 partiiandiii.htm PART II AND III 1386779
3 ex1-2.htm ADD EXHB 53952
4 ex4-1.htm ADD EXHB 115320
5 ex11-1.htm ADD EXHB 967
6 ex12-1.htm ADD EXHB 10605
7 part2and3_001.jpg GRAPHIC 7820
8 ex1-2_001.jpg GRAPHIC 11628
9 ex11-1_001.jpg GRAPHIC 338621
  Complete submission text file 0001493152-22-012733.txt   2073657
Mailing Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367
Business Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367 (800) 489-4774
ENDONOVO THERAPEUTICS, INC. (Filer) CIK: 0001528172 (see all company filings)

IRS No.: 452552528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 1-A/A | Act: 33 | File No.: 024-11805 | Film No.: 22911202
SIC: 2834 Pharmaceutical Preparations